Literature DB >> 27059169

Influence of food and lifestyle on the risk of developing inflammatory bowel disease.

O Niewiadomski1, C Studd2, J Wilson3, J Williams1, C Hair4, R Knight4, E Prewett4, P Dabkowski4, S Alexander4, B Allen4, D Dowling4, W Connell1, P Desmond1, S Bell1.   

Abstract

BACKGROUND: The Barwon area in Australia has one of the highest incidence rates of inflammatory bowel disease (IBD) and therefore is an ideal location to study the impact of environmental exposures on the disease's development. AIM: To study these exposures prior to the development of IBD in a population-based cohort.
METHOD: One hundred and thirty-two incident cases (81 Crohn disease (CD) and 51 ulcerative colitis (UC)) from an IBD registry and 104 controls replied to the International Organization of Inflammatory Bowel Diseases environmental questionnaire. This included 87 questions about pre-illness exposures that included childhood illnesses, vaccinations, breastfeeding, house amenities, pets and swimming, diet and smoking.
RESULTS: The factors associated with CD included smoking (odds ratio (OR): 1.42, confidence interval (CI): 1-2.02, P = 0.029); childhood events, including tonsillectomy (OR: 1.74, CI: 1.15-2.6, P = 0.003) and chicken pox infection (OR: 3.89, CI: 1.61-9.4, P = 0.005) and pre-diagnosis intake of frequent fast food (OR: 2.26, CI: 1.76-4.33, P = 0.003). In UC, the risk factors included smoking (OR: 1.39, CI: 1.1-1.92, P = 0.026) and pre-diagnosis intake of frequent fast food (OR: 2.91, CI: 1.54-5.58, P < 0.001), and high caffeine intake was protective (OR: 0.51, 95% CI: 0.3-0.87, P = 0.002). Other protective exposures for UC included high fruit intake (OR: 0.59, CI: 0.4-0.88, P = 0.003) and having pets as a child (OR: 0.36, CI: 0.2-0.79, P = 0.001).
CONCLUSION: This first Australian population-based study of environmental risk factors confirms that smoking, childhood immunological events and dietary factors play a role in IBD development; while high caffeine intake and pet ownership offer a protective effect.
© 2016 Royal Australasian College of Physicians.

Entities:  

Keywords:  Crohn disease; aetiology; environmental factors; epidemiology; inflammatory bowel disease; ulcerative colitis

Mesh:

Year:  2016        PMID: 27059169     DOI: 10.1111/imj.13094

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  24 in total

Review 1.  Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis.

Authors:  L Xu; P Lochhead; Y Ko; B Claggett; R W Leong; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-09-11       Impact factor: 8.171

Review 2.  The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.

Authors:  Christopher A Lamb; Aamir Saifuddin; Nick Powell; Florian Rieder
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

Review 3.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 4.  Role of Diet in the Development and Management of Crohn's Disease.

Authors:  Donald Goens; Dejan Micic
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

5.  Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study.

Authors:  Carmen Monica Preda; Teodora Manuc; Doina Istratescu; Edouard Louis; Cristian Baicus; Irina Sandra; Mircea Diculescu; Catherine Reenaers; Catherine van Kemseke; Maria Nitescu; Cristian Tieranu; Corina Georgiana Sandu; Gabriela Oprea-Calin; Letitia Tugui; Siyana Viziru; Cosmin-Alexandru Ciora; Liliana-Simona Gheorghe; Mircea Manuc
Journal:  Maedica (Buchar)       Date:  2019-09

6.  Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.

Authors:  Inga Peter; Marla Dubinsky; Susan Bressman; Andrew Park; Changyue Lu; Naijun Chen; Anthony Wang
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

7.  The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study.

Authors:  Severin A Lautenschlager; Nicolas Fournier; Luc Biedermann; Valerie Pittet; Philipp Schreiner; Benjamin Misselwitz; Michael Scharl; Gerhard Rogler; Alexander R Siebenhüner
Journal:  Inflamm Intest Dis       Date:  2020-08-26

8.  Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study.

Authors:  Satimai Aniwan; William J Tremaine; Laura E Raffals; Sunanda V Kane; Edward V Loftus
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

9.  Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses.

Authors:  Manasi Agrawal; João Sabino; Catarina Frias-Gomes; Christen M Hillenbrand; Celine Soudant; Jordan E Axelrad; Shailja C Shah; Francisco Ribeiro-Mourão; Thomas Lambin; Inga Peter; Jean-Frederic Colombel; Neeraj Narula; Joana Torres
Journal:  EClinicalMedicine       Date:  2021-05-15

Review 10.  The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Tony Long; Daniel van Langenberg
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.